Xtrava Health focuses on enhancing the accessibility and accuracy of COVID-19 testing through innovative diagnostic solutions. Their flagship product, the SPERA™ COVID-19 Antigen Test, is an FDA EUA-authorized rapid antigen test designed for point-of-care use. This technology allows for efficient testing in various settings, including health clinics, drive-up testing centers, and event venues. By prioritizing ease of use and cost-effectiveness, Xtrava Health aims to provide a high-volume testing solution that meets the urgent needs of communities during the pandemic.

The company leverages next-generation technology and strategic global partnerships to develop and commercialize diagnostic products that are both user-friendly and reliable. Xtrava Health is committed to empowering healthcare providers and facilitating at-home disease detection, thereby promoting early diagnosis and intervention. Their mission is to make testing accessible to everyone, enabling individuals to return to their daily lives with confidence and safety. Through these efforts, Xtrava Health is positioned as a key player in the ongoing response to the COVID-19 crisis.

United States

Xtrava Health is a Silicon Valley company, founded in 2014, on a vision to bridge the gap between diagnostics and everyday users. Leveraging next generation technology and strategic global partnerships, Xtrava Health develops, manufactures, and commercializes easy-to-use, accurate, and affordable diagnostic products for health professionals and at-home use. 

We are on the forefront in the battle against the COVID-19 pandemic and committed to increasing the availability, ease, and accuracy of COVID-19 tests, to reach those who need it most.

Xtrava Health

Company Details